Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer

Clinical trial NCT00100841 · COMPLETED

Trial details

NCT number: NCT00100841
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Rectum Mucinous Adenocarcinoma of the Colon Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Stage IV Colon Cancer Stage IV Rectal Cancer

Start date: 2004-11-01
Primary completion: 2011-07-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.